ArticleOncology letters2021

Erratum: lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma.

Hideharu Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.